As a consequence, hyperactivation of lipogenesis, which has been previously demonstrated to be directly activated by AGEs21,43, was enhanced, while the increased expression of Gal-3 contributed to both the persistent NLRP3 inflammasome activation, not depending on NFkB, and steatosis. The gene discussed is LGALS3; the disease is steatosis.